Genentech

10 drugmakers team up to improve testing process
Yahoo/AP
Thu, 09/20/12 - 10:38 am
TransCelerate BioPharma
Pfizer
JNJ
Bristol-Myers Squibb
Eli Lilly
Abbott Laboratories
GSK
AstraZeneca
Sanofi
Boehringer Ingelheim
Genentech
Roche Worker Sues For Whistleblowing & Firing
Pharmalot
Tue, 08/14/12 - 11:00 am
Roche
Genentech
whistleblower lawsuits
FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
Pipeline Review
Sat, 08/11/12 - 12:57 pm
Lucentis
Genentech
Roche
diabetic macular edema
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Seeking Alpha
Tue, 06/19/12 - 12:10 pm
breast cancer
PDL Biopharma
Genentech
Roche
Symmetry Medical
Rigel
Medivation
MRI Interventions
BioSante
Horizon Pharma
Pertuzumab
Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP
Sun, 06/3/12 - 11:13 am
T-DM1
breast cancer
Genentech
Roche
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
Pipeline Review
Sun, 03/25/12 - 12:39 pm
Synthon Pharmaceuticals
trastuzumab
Herceptin
breast cancer
gastric cancer
biosimilars
Genentech
Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin
Bloomberg
Fri, 03/23/12 - 11:30 am
lawsuits
Sanofi
Roche
Rituxan
Avastin
Genentech
Biogen Idec
Roche Settles Claims Over Genentech’s Raptiva Psoriasis Drug, Lawyer Says
Bloomberg
Tue, 01/24/12 - 10:57 am
Raptiva
settlements
Roche
Genentech
psoriasis
Regeneron settles with Genentech over eye drug
Yahoo/AP
Tue, 01/3/12 - 11:29 am
Regeneron
Genentech
Eyelea
New Setback for Avastin as Breast Cancer Treatment
NY Times, NY
Thu, 12/8/11 - 11:39 am
breast cancer
Avastin
Roche
Genentech
Big promise is seen in 2 new breast cancer drugs
Yahoo/AP
Wed, 12/7/11 - 10:13 pm
breast cancer
Genentech
Pertuzumab
Afinitor
Novartis
Genmab says rivals appeal U.S. ruling in patent suit
Reuters
Tue, 12/6/11 - 11:33 am
patents
Genmab
Biogen Idec
Genentech
GSK
Arzerra
F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Fri, 11/18/11 - 11:51 am
FDA
Avastin
breast cancer
Roche
Genentech
VA Reinstates Avastin Usage For Eye Disease
Pharmalot
Thu, 11/10/11 - 01:13 pm
Veterans Administration
Avastin
Lucentis
age-related macular degeneration
Genentech
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Curis
milestone payments
FDA
basal cell carcinoma
Genentech
vismodegib
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Seeking Alpha
Sun, 10/16/11 - 07:05 pm
Micromet
Pfizer
blinatumomab
acute lymphoblastic leukemia
leukemia
Bmab
SAR3419
Sanofi
inotuzumab
Genentech
Seattle Genetics

Pages